JP2018504609A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018504609A5 JP2018504609A5 JP2017541693A JP2017541693A JP2018504609A5 JP 2018504609 A5 JP2018504609 A5 JP 2018504609A5 JP 2017541693 A JP2017541693 A JP 2017541693A JP 2017541693 A JP2017541693 A JP 2017541693A JP 2018504609 A5 JP2018504609 A5 JP 2018504609A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- biosensor
- concentration
- reg1
- motomeko
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1501930.0 | 2015-02-05 | ||
| GBGB1501930.0A GB201501930D0 (en) | 2015-02-05 | 2015-02-05 | Biomarkers for pancreatic cancer |
| PCT/GB2016/050277 WO2016124947A1 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018504609A JP2018504609A (ja) | 2018-02-15 |
| JP2018504609A5 true JP2018504609A5 (OSRAM) | 2019-03-14 |
| JP6786499B2 JP6786499B2 (ja) | 2020-11-18 |
Family
ID=52746188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017541693A Active JP6786499B2 (ja) | 2015-02-05 | 2016-02-05 | 膵癌のバイオマーカー |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10782301B2 (OSRAM) |
| EP (2) | EP3254111A1 (OSRAM) |
| JP (1) | JP6786499B2 (OSRAM) |
| KR (1) | KR102569984B1 (OSRAM) |
| CN (1) | CN107533062B (OSRAM) |
| AU (1) | AU2016214140B2 (OSRAM) |
| BR (1) | BR112017016808A2 (OSRAM) |
| CA (1) | CA2974775C (OSRAM) |
| CL (1) | CL2017001972A1 (OSRAM) |
| GB (1) | GB201501930D0 (OSRAM) |
| HK (1) | HK1247276A1 (OSRAM) |
| IL (1) | IL253710B (OSRAM) |
| MX (1) | MX2017009998A (OSRAM) |
| SG (1) | SG11201706223VA (OSRAM) |
| WO (1) | WO2016124947A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3851856A3 (en) | 2007-03-27 | 2021-11-03 | Immunovia AB | Method, array and use thereof |
| GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
| GB201517028D0 (en) * | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
| CN107674884A (zh) * | 2017-09-05 | 2018-02-09 | 上海速创诊断产品有限公司 | 一种用于检测胰腺癌标记物reg1a的生物素化脂质体及其制备方法和应用 |
| TWI643869B (zh) * | 2017-12-14 | 2018-12-11 | 國立高雄大學 | Molecular extension printing material and preparation method thereof, magnetic molecular extension printing material and preparation method thereof |
| US20210052231A1 (en) * | 2017-12-14 | 2021-02-25 | Salcit Technologies Private Limited | Method and system for analyzing risk associated with respiratory sounds |
| KR102000387B1 (ko) * | 2018-02-13 | 2019-07-15 | 서울대학교산학협력단 | 췌관내유두상점액종양의 악성도를 감별할 수 있는 단백질 바이오마커 및 그 용도 |
| CN109358055A (zh) * | 2018-12-18 | 2019-02-19 | 沈阳理工大学 | 增敏测定空气中氨的混合指示剂试纸及其制备和检测方法 |
| CN111303281A (zh) * | 2019-05-14 | 2020-06-19 | 长春恒晓生物科技有限责任公司 | 制备胰石蛋白抗体及建立检测psp方法 |
| EP4045912A1 (en) * | 2019-10-18 | 2022-08-24 | Reccan Diagnostics AB | Apparatuses and methods for detection of pancreatic cancer |
| GB202010970D0 (en) * | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN113248609B (zh) * | 2021-07-14 | 2021-09-10 | 深圳市盛波尔生命科学技术有限责任公司 | 针对再生胰岛衍生蛋白1α的抗体组合以及包含其的检测试剂盒 |
| CN115290732B (zh) * | 2022-07-14 | 2025-02-25 | 西北大学 | 一种检测胰蛋白酶的电化学生物传感器及其制备方法 |
| CN119724622B (zh) * | 2024-11-25 | 2025-12-12 | 中国人民解放军总医院第五医学中心 | 一种评价ptt对胰腺癌治疗效果的方法、系统及设备 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| US7601826B2 (en) * | 2002-09-30 | 2009-10-13 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human pancreatic cancers |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| US20050095611A1 (en) | 2003-05-02 | 2005-05-05 | Chan Daniel W. | Identification of biomarkers for detecting pancreatic cancer |
| AU2004239418A1 (en) | 2003-05-15 | 2004-11-25 | Europroteome Ag | Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer |
| DE102004042822A1 (de) | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen |
| CA2595377A1 (en) | 2005-01-28 | 2006-08-03 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
| AU2006261671A1 (en) | 2005-06-27 | 2007-01-04 | John Wayne Cancer Institute | Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome |
| WO2007035684A2 (en) | 2005-09-16 | 2007-03-29 | Primera Biosystems, Inc. | Method for quantitative detection of short rna molecules |
| WO2007081680A2 (en) | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
| WO2007098102A2 (en) | 2006-02-17 | 2007-08-30 | Children's Medical Center Corporation | Free ngal as a biomarker for cancer |
| US20070231822A1 (en) | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| EP2115138A2 (en) | 2006-09-19 | 2009-11-11 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| US20080199455A1 (en) | 2006-10-03 | 2008-08-21 | Lobie Peter E | Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| US20100092476A1 (en) | 2006-11-17 | 2010-04-15 | Hanash Samir M | Pancreatic cancer biomarkers |
| EP2142659A4 (en) | 2007-04-30 | 2010-06-09 | Univ Ohio State Res Found | METHOD FOR THE DISTINCTION OF PANCREATIC CANCER OF NORMAL IMMERSION SPECTRUM FUNCTIONS AND CHRONIC IMMERSION IMAGING IGNITION |
| CA2723972A1 (en) | 2008-05-12 | 2009-11-19 | Genomic Health Inc. | Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| WO2009147530A2 (en) | 2008-06-06 | 2009-12-10 | Neuren Pharmaceuticals Ltd | Conformation specific antibodies that bind trefoil factors |
| JP2012100536A (ja) * | 2009-03-02 | 2012-05-31 | Genescience Co Ltd | 血液試料に含まれる単核球細胞を用いた癌関連遺伝子の発現解析による癌の遺伝子検査方法 |
| EP3075390A1 (en) * | 2010-01-19 | 2016-10-05 | Immunomedics Inc. | Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r) |
| EP2415877A3 (en) * | 2010-02-17 | 2012-02-15 | Deutsches Krebsforschungszentrum | Means and methods for diagnosing pancreatic cancer |
| WO2011137288A2 (en) | 2010-04-30 | 2011-11-03 | The Ohio State University | Mirna networks in cancers and leukemias and uses thereof |
| WO2012100339A1 (en) * | 2011-01-27 | 2012-08-02 | University Health Network | Methods and compositions for the detection of pancreatic cancer |
| US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
| EP2758079A4 (en) | 2011-09-21 | 2015-05-13 | Univ North Carolina | PROCESS WITH BIOMARKERS FOR LIVER DISEASE |
| DE102012204366B4 (de) | 2011-12-16 | 2017-07-27 | Siemens Aktiengesellschaft | Verfahren und Kit zur Identifizierung und Quantifizierung von einer einzelsträngigen Ziel-Nukleinsäure |
| US20150018235A1 (en) | 2012-01-13 | 2015-01-15 | Oncocyte Corporation | Methods and Compositions for the Treatment and Diagnosis of Pancreatic Cancer |
| US20150011414A1 (en) | 2012-01-16 | 2015-01-08 | Herlev Hospital | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples |
| US20130216545A1 (en) | 2012-02-19 | 2013-08-22 | Claresa Levetan | Early Diagnosis and Novel Treatment of Cancer |
| WO2013152989A2 (en) * | 2012-04-10 | 2013-10-17 | Eth Zurich | Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer |
| US20130317083A1 (en) | 2012-05-04 | 2013-11-28 | Thomas Jefferson University | Non-coding transcripts for determination of cellular states |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| US20140271621A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods of prognosis and diagnosis of pancreatic cancer |
| US20150018230A1 (en) | 2013-06-11 | 2015-01-15 | Indiana University Research And Technology Corp. | PLASMA miRNA SIGNATURE FOR THE ACCURATE DIAGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA |
| GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
| GB201517028D0 (en) | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
-
2015
- 2015-02-05 GB GBGB1501930.0A patent/GB201501930D0/en not_active Ceased
-
2016
- 2016-02-05 WO PCT/GB2016/050277 patent/WO2016124947A1/en not_active Ceased
- 2016-02-05 HK HK18106404.7A patent/HK1247276A1/zh unknown
- 2016-02-05 EP EP16703840.5A patent/EP3254111A1/en active Pending
- 2016-02-05 CA CA2974775A patent/CA2974775C/en active Active
- 2016-02-05 BR BR112017016808A patent/BR112017016808A2/pt not_active Application Discontinuation
- 2016-02-05 EP EP24188089.7A patent/EP4458849A3/en active Pending
- 2016-02-05 US US15/548,240 patent/US10782301B2/en active Active
- 2016-02-05 KR KR1020177024461A patent/KR102569984B1/ko active Active
- 2016-02-05 JP JP2017541693A patent/JP6786499B2/ja active Active
- 2016-02-05 MX MX2017009998A patent/MX2017009998A/es unknown
- 2016-02-05 AU AU2016214140A patent/AU2016214140B2/en active Active
- 2016-02-05 CN CN201680018784.8A patent/CN107533062B/zh active Active
- 2016-02-05 SG SG11201706223VA patent/SG11201706223VA/en unknown
-
2017
- 2017-07-28 IL IL253710A patent/IL253710B/en active IP Right Grant
- 2017-08-02 CL CL2017001972A patent/CL2017001972A1/es unknown
-
2020
- 2020-08-26 US US17/003,139 patent/US11977077B2/en active Active
-
2024
- 2024-04-02 US US18/624,620 patent/US20250251399A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018504609A5 (OSRAM) | ||
| Yekula et al. | From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers | |
| Lee et al. | Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC) | |
| JP6786499B2 (ja) | 膵癌のバイオマーカー | |
| JP2011526693A5 (OSRAM) | ||
| Joyce et al. | Prospective changes in global DNA methylation and cancer incidence and mortality | |
| Sajjadi et al. | Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test | |
| Tan et al. | Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer | |
| JP2019150027A5 (OSRAM) | ||
| KR20130119335A (ko) | 대상체에서 췌장암을 진단하기 위한 수단 및 방법 | |
| JP2014509515A5 (OSRAM) | ||
| Zhou et al. | Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer | |
| JP6857185B2 (ja) | 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法 | |
| RU2015118294A (ru) | Синтетическая летальность и лечение рака | |
| JP2014531046A (ja) | 疾病バイオマーカーの同定及び試料品質の評価のための好ましい試料操作及び加工プロトコルの選択 | |
| US20210063334A1 (en) | Apparatus and methods for detection of diabetes-associated molecules using electrochemical impedance spectroscopy | |
| Marshall et al. | Strategies for biomarker discovery in fibrotic disease | |
| Eroglu et al. | Analysis of circulating tumor cells in breast cancer | |
| CN110914687A (zh) | 血浆微量样品中肿瘤源性细胞外囊泡的纳米等离激元定量 | |
| JP2018529931A5 (OSRAM) | ||
| KR20200085390A (ko) | Ripk3을 포함하는 당뇨병성 신증 진단용 바이오마커 및 이의 용도 | |
| Yang et al. | Expression of neuron-specific enolase in multiple myeloma and implications for clinical diagnosis and treatment | |
| CN105849566A (zh) | 肾脏疾病生物标志物 | |
| JP2016519767A5 (OSRAM) | ||
| Song et al. | Diagnostic accuracy of exosomal long noncoding RNAs in diagnosis of NSCLC: a meta-analysis |